Tabata, R., Kaji, D., Yamamoto, G., Kuno, M., Watanabe, O., Yamaguchi, K., Kageyama, K., Taya, Y., Nishida, A., Ishiwata, K., Takagi, S., Yamamoto, H., Asano-Mori, Y., Wake, A., Taniguchi, S., Uchida, N. (2025). A simple, 3-factor pre-treatment score (Toranomon Prognostic Score) robustly stratifies progression risk in patients with relapsed/refractory large B-cell lymphoma receiving commercial CAR T-cell therapy: A real-world analysis. Blood. https://doi.org/10.1182/blood-2025-1942